Preanalytical quality improvement: from dream to reality
Giuseppe Lippi(University of Verona), Ana-Maria Šimundić(University of Zagreb), Mario Plebani(University of Padua), Ken Sikaris, Stephen Church(Bioanalytical Systems (United States)), Davide Giavarina(International Renal Research Institute of Vicenza), Vladimír Palička(University Hospital Hradec Králové), Sverre Sandberg(University of Bergen), Gian Luca Salvagno, Kjell Grankvist(Umeå University), Vincenzo Puro(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Ian D. Watson(University of Liverpool), Ana K. Stanković(Bioanalytical Systems (United States)), Jeffrey J. Chance(Bioanalytical Systems (United States)), Timo Kouri(University of Helsinki), Rossana Fontana(University Hospitals Parma Medical Center), Wim Huisman
Cited by 378
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference
|JAMA Network Open|2020|644
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients
|Diabetes Care|2007|579
European Urinalysis Guidelines
|Scandinavian Journal of Clinical and Laboratory Investigation|2000|384
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
|Clinica Chimica Acta|2020|337